What medications are contraindicated with metformin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications and Conditions Contraindicated with Metformin

Metformin is contraindicated in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis including diabetic ketoacidosis, and hypersensitivity to metformin. 1

Absolute Contraindications

Renal Impairment

  • Severe renal impairment (eGFR <30 mL/min/1.73 m²) is an absolute contraindication 1
  • Initiation is not recommended when eGFR is 30-45 mL/min/1.73 m² 1
  • If eGFR falls below 45 mL/min/1.73 m² during treatment, assess benefit-risk and consider discontinuation 1
  • Metformin should be discontinued if eGFR falls below 30 mL/min/1.73 m² 1
  • The KDIGO guidelines recommend reviewing metformin use at eGFR 30-44 mL/min/1.73 m² and discontinuing at eGFR <30 mL/min/1.73 m² 2

Metabolic Acidosis

  • Acute or chronic metabolic acidosis, including diabetic ketoacidosis (with or without coma), is an absolute contraindication 1

Hepatic Impairment

  • Metformin is not recommended in patients with hepatic impairment due to increased risk of lactic acidosis 1
  • The EASL guidelines explicitly state metformin should not be used in decompensated cirrhosis 3
  • Metformin should be avoided in patients with significant ALT elevation 3
  • Known hepatic disease is a contraindication 2

Temporary Discontinuation Required

Iodinated Contrast Procedures

  • Discontinue metformin at the time of or prior to iodinated contrast imaging in specific high-risk patients: 1

    • Patients with eGFR 30-60 mL/min/1.73 m²
    • Patients with history of liver disease
    • Patients with alcoholism
    • Patients with heart failure
    • Patients receiving intra-arterial iodinated contrast
  • Re-evaluate eGFR 48 hours after the procedure; restart metformin only if renal function is stable 1

  • The KDIGO guidelines recommend withdrawing potentially nephrotoxic agents before and after contrast procedures 2

Acute Illness and Hospitalization

  • Temporarily discontinue metformin during: 2
    • Procedures requiring iodinated contrast
    • Hospitalizations
    • Any acute illness associated with dehydration or hypoxemia
    • Acute illness that may compromise renal or liver function

Conditions Requiring Caution

Cardiovascular Conditions

  • Use with caution in patients with impaired cardiac function or heart failure due to increased lactic acidosis risk 2
  • Hypoxemic conditions are contraindications 2
  • Conditions causing decreased tissue perfusion or hemodynamic instability are contraindications 2

Other High-Risk Conditions

  • Alcohol abuse is a contraindication 2
  • Severe infections require temporary discontinuation 2
  • Any condition that might lead to lactic acidosis is a contraindication 2

Important Clinical Considerations

Lactic Acidosis Risk

  • The primary concern with metformin contraindications is the risk of lactic acidosis, though this risk is extremely low when used appropriately 2
  • Metformin itself does not cause hypoglycemia when used as monotherapy 4
  • The prognosis of lactic acidosis is mainly related to underlying hypoxic disease and comorbidities rather than metformin levels alone 5

Monitoring Requirements

  • Assess renal function prior to initiation and periodically thereafter 1
  • More frequent renal function assessment is needed in elderly patients 1
  • Regular monitoring of liver function tests is essential in patients with known liver disease 3

Special Populations

  • Elderly patients: Dose selection should be cautious, starting at the low end of the dosing range, with more frequent renal function assessment 1
  • Pregnancy: No oral agents, including metformin, should be used during pregnancy 2
  • Premenopausal women: Metformin may restore ovulation in anovulatory women, increasing risk of unintended pregnancy; provide preconception counseling 2, 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metformin Use in Patients with Elevated Liver Enzymes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metformin Poisoning and Hypoglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.